<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Glutamine dependence &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/glutamine-dependence/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 09 Jan 2026 22:46:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Glutamine dependence &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Amino Acid Metabolism: New Hope for Cholangiocarcinoma</title>
		<link>https://bioengineer.org/amino-acid-metabolism-new-hope-for-cholangiocarcinoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 22:46:37 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Amino acid targeting]]></category>
		<category><![CDATA[Glutamine dependence]]></category>
		<category><![CDATA[Immunometabolism** **Kısa açıklama:** 1. **Cholangiocarcinoma metabolism:** Ana konu olan kolanjiyokarsinomun metabolizmasına doğrudan işaret eder. 2. **Amino acid targeting:** Makalenin terapötik]]></category>
		<category><![CDATA[İşte 5 adet uygun etiket: **Cholangiocarcinoma metabolism]]></category>
		<category><![CDATA[Metabolic Reprogramming]]></category>
		<guid isPermaLink="false">https://bioengineer.org/amino-acid-metabolism-new-hope-for-cholangiocarcinoma/</guid>

					<description><![CDATA[Cholangiocarcinoma (CCA), particularly its intrahepatic subtype (iCCA), remains one of the most formidable challenges in oncology today. This malignancy is typified by late diagnosis and limited therapeutic options, due largely to its insidious onset and the absence of effective early biomarkers. Despite conventional treatment regimens, including the standard use of gemcitabine and cisplatin chemotherapy, patient [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315473</post-id>	</item>
	</channel>
</rss>
